apollo
0
Written By Santoshini Reddy G , M Pharmacy
Reviewed By ,
Last Updated Sep 30, 2024 | 4:52 PM IST

Eylea 40mg/ml Injection is an anti-angiogenic ophthalmic agent used to treat wet age-related macular degeneration, macular oedema, diabetic macular oedema, diabetic retinopathy, and retinopathy of prematurity. It contains Aflibercept, a vascular endothelial growth factor-A (VEGF-A) and placental growth factor (PlGF) antagonist. It works by stopping abnormal blood vessel growth and leakage in the eyes that may cause vision loss in people with eye conditions. It helps stabilise and improve vision loss.

Read more
Prescription drug

Whats That

tooltip
Prescription drug
 Trailing icon
Consult Doctor

Composition

AFLIBERCEPT-40MG

Manufacturer/Marketer

Bayer Zydus Pharma Pvt Ltd

Consume Type

PARENTERAL

Return Policy

Not Returnable

Expires on or after

Jan-27

for this medicine

About Eylea 40mg/ml Injection

Eylea 40mg/ml Injection belongs to the group of medicines called anti-angiogenic ophthalmic agents. It is mainly used to treat wet age-related macular degeneration, and macular edema after retinal vein occlusion. It is also used to treat diabetic macular oedema, diabetic retinopathy, and retinopathy of prematurity.

Eylea 40mg/ml Injection contains Aflibercept, which is a vascular endothelial growth factor-A (VEGF-A) and placental growth factor (PlGF) antagonist. It works by stopping abnormal blood vessel growth and leakage in the eyes that may cause vision loss in people with eye conditions.

Eylea 40mg/ml Injection will be administered by the doctor; do not self-administer. In some cases, Eylea 40mg/ml Injection may cause side effects such as eye pain, bleeding in the back of the eye, cataracts, bloodshot eyes and deterioration of eyesight. You are advised to talk to the doctor if any of the side effects persist or worsen.

Let the doctor know about your allergic history before using Eylea 40mg/ml Injection. Discontinue and inform your physician if the patient develops any allergic reactions. Consult the doctor if you are pregnant, think you may be pregnant or are planning for pregnancy. Eylea 40mg/ml Injection is not recommended during breastfeeding. Keep the doctor informed about your health condition and medications to rule out any side effects.

Uses of Eylea 40mg/ml Injection

Treatment of Wet age-related macular degeneration, Macular oedema after retinal vein occlusion, Diabetic macular oedema, Diabetic retinopathy, and Retinopathy of prematurity

Medicinal Benefits

Eylea 40mg/ml Injection is an anti-angiogenic ophthalmic agent used to treat wet age-related macular degeneration, macular oedema, diabetic macular oedema and diabetic retinopathy, and retinopathy of prematurity. Eylea 40mg/ml Injection contains Aflibercept, a vascular endothelial growth factor-A (VEGF-A) and placental growth factor (PlGF) antagonist. It works by stopping abnormal blood vessel growth and leakage in the eyes that may cause vision loss in people with eye conditions. It helps stabilise and improve vision loss.

Directions for Use

Eylea 40mg/ml Injection will be administered by a healthcare professional; do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Eylea 40mg/ml Injection

  • Eye pain
  • Bloodshot eye
  • Deterioration of eyesight
  • Bleeding in the back of the eye
  • Swelling of the eyelid
  • Increase in eye pressure
  • Cataract

Drug Warnings

Do not receive Eylea 40mg/ml Injection if you are allergic to any of its components. This medicine is contraindicated in patients with any history of allergies, active or suspected infection in or around the eye, or if you have severe eye inflammation (pain or redness in the eye). Consult the doctor if you are pregnant, think you may be pregnant, or are planning for pregnancy. Let your doctor know if you have any conditions like glaucoma, blood clot, stroke, a history of seeing flashes of light or floaters, if you have a sudden increase in size and the number of floaters or if you have undergone or are due to undergo any eye surgery. Let the doctor know if you are taking any other medicines, including supplements or herbal products. Eylea 40mg/ml Injection is not recommended for use in children. It is advised to discontinue the medicine and inform your attending doctor if you have any allergic reactions while receiving Eylea 40mg/ml Injection.

Drug Interactions

Drug-Drug Interactions: Inform the doctor if you are using or have recently used any other medicines.

Drug-Food Interactions: No interactions were found.

Drug-Disease Interactions: Inform the doctor if you have an active or suspected infection in or around the eye or severe eye inflammation (pain or redness in the eye).

Habit Forming

No

Diet & Lifestyle Advise

  • Eat a healthy diet and exercise regularly to maintain proper weight.
  • Avoid smoking and alcohol consumption.
  • Include vegetables, whole grains, and fruits in your diet.
  • Get optimal sleep; rest well.

Special Advise

  • Women of reproductive potential must use effective contraception during treatment with Eylea 40mg/ml Injection and for 3 months after the last dose.

Disease/Condition Glossary

Wet age-related macular degeneration (AMD): Age-related macular degeneration is an eye disease that causes vision loss. In wet macular degeneration, leaky blood vessels grow under the retina, which causes loss of the ability to see straight ahead and difficulty in reading, driving or performing daily activities.

Macular oedema after retinal vein occlusion: It occurs when blood vessels leak into the macula (a part of the retina). This causes macula swelling and blurred vision. Retinal vein occlusion is the blockage of small veins that carry blood away from the retina, occurring due to the hardening of arteries or the formation of blood clots. Symptoms include sudden blurring or vision loss.

Diabetic macular oedema: It is a complication of diabetes that occurs when excess fluid starts to build up in the macula of the eye, leading to vision problems. Symptoms are blurry vision, double vision, seeing floaters, and seeing colours that look washed out.

Diabetic retinopathy: It is a diabetic eye disease that occurs when the retina starts growing new blood vessels. Symptoms are vision loss, poor night vision, colours appearing faded or washed out, blurry vision, and seeing an increasing number of floaters.

Retinopathy of prematurity (ROP): ROP is a disease-causing vision impairment due to damage to the back of the eye (the retina) caused by abnormal growth of blood vessels.

bannner image

Alcohol

Consult your doctor

It is not known if alcohol interacts with Eylea 40mg/ml Injection. Please consult the doctor.

bannner image

Pregnancy

Caution

Aflibercept belongs to pregnancy category C. Eylea 40mg/ml Injection should be used during pregnancy only if the benefits outweigh the risks. Women of reproductive potential must use effective birth control pills to avoid pregnancy.

bannner image

Breast Feeding

Caution

Small amounts of the medicine may pass into breast milk. Your doctor will decide whether to discontinue nursing or the medicine, taking into account the importance of the medicine to the mother.

bannner image

Driving

Unsafe

Eylea 40mg/ml Injection may cause temporary vision disturbances. Avoid driving or operating heavy machinery if you experience this.

bannner image

Liver

Consult your doctor

If you have a history of liver problems, inform the doctor before receiving Eylea 40mg/ml Injection.

bannner image

Kidney

Consult your doctor

If you have a history of kidney problems, inform the doctor before receiving Eylea 40mg/ml Injection.

bannner image

Children

Caution

The safety and effectiveness of Eylea 40mg/ml Injection in children have not been established except for retinopathy of prematurity. However, please consult the paediatrician if you have any concerns.

Country of origin

INDIA

Manufacturer/Marketer address

Bayer House, Central Avenue, Hiranandani Estate, Thane (west) Thane 400607 India
Other Info - EYL0002

FAQs

Eylea 40mg/ml Injection is used to treat Wet age-related macular degeneration, Macular oedema after retinal vein occlusion, Diabetic macular oedema, Diabetic retinopathy, and Retinopathy of prematurity.
Eylea 40mg/ml Injection works by stopping abnormal blood vessel growth and leakage in the eyes that may cause vision loss in people with eye conditions.
In some patients, Eylea 40mg/ml Injection may cause intraocular pressure (an increase in eye pressure) after administering Eylea 40mg/ml Injection. Hence, your doctor will monitor this condition after each administration.
Limited data is available regarding the safety of Eylea 40mg/ml Injection in patients who have had a stroke, mini-stroke, or heart attack. Inform your doctor if you have had a stroke or heart attack. Your doctor will administer Eylea 40mg/ml Injection with caution.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
icon image

Keep Refrigerated. Do not freeze.Prepaid payment required.

Add to Cart